Avation Medical: Neuromodulation And Digital Health Company Raises $22 Million
By Annie Baker ● Feb 2, 2024
Avation Medical - an innovative neuromodulation and digital health company with a goal to make wearable peripheral neuromodulation accessible to patients across a variety of clinical conditions - announced over $22 million in equity financing in its oversubscribed Series C round, led by new investors ShangBay Capital and Asahi Kasei, which included Angelini Ventures, JobsOhio Growth Capital Fund, and others. Additional investments were also provided by Arboretum Ventures, Tonkawa, Medtronic, and Avestria Ventures. The funding in the round (which remains open) will be used for the U.S. launch of the company's Vivally System.